Blystad, A K <br/><br/>
CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD.  [electronic resource] 

 -  Cytotherapy  2001 
 - 295-305 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3249 
<br/><br/><label>Standard No.: </label>10.1080/146532401317070934  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antigens, CD34--immunology<br/>Biomarkers--analysis<br/>Biomarkers, Tumor--analysis<br/>Bone Marrow Cells--immunology<br/>Child<br/>Female<br/>Graft Survival--immunology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hodgkin Disease--immunology<br/>Humans<br/>Immunohistochemistry--instrumentation<br/>Immunomagnetic Separation--instrumentation<br/>Ki-1 Antigen--immunology<br/>Lymphocytes--cytology<br/>Male<br/>Middle Aged<br/>Neoplastic Cells, Circulating--immunology<br/>Platelet Transfusion<br/>Recurrence<br/>Survival Rate<br/>Treatment Outcome